Theravance Biopharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Theravance Biopharma's balance sheet done over the years? Its assets were worth $381,999,000 last year, which is less than in the previous period. 44% of Theravance Biopharma’s total assets is currently financed by debt. Its liabilities reached the amount of $169,004,000, which means an increase by 2% compared compared to last year.
Debt to Assets
| 2014 | 337771000 | 47.98M | 14.21% |
|---|---|---|---|
| 2015 | 300116000 | 57.05M | 19.01% |
| 2016 | 639254000 | 289.02M | 45.21% |
| 2017 | 441400000 | 326.22M | 73.91% |
| 2018 | 560235000 | 611.82M | 109.21% |
| 2019 | 408826000 | 632.66M | 154.75% |
| 2020 | 469057000 | 772.80M | 164.76% |
| 2021 | 374819000 | 713.39M | 190.33% |
| 2022 | 607400000 | 165.6M | 27.26% |
| 2023 | 381999000 | 169.00M | 44.24% |
TBPH Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 39.54M | 298.17M | 89.95M | 81.46M | 58.06M | 378.02M | 88.98M | 344.70M | 112.70M | 89.21M |
Short term investments | 62.88M | 29.31M | 83.50M | 211.47M | 222.76M | 127.25M | 259.58M | 156.38M | 59.72M | 165.39M |
Net receivables | 17.47M | 16.78M | 57.59M | 69.66M | 50.57M | 10.05M | 9.36M | 9.07M | 37.15M | 2.12M |
Inventory | 0 | 1.51M | 10.24M | 20.37M | 1 | 0 | 16.83M | 12.22M | 10.00M | 12.54M |
Other current assets | 13.64M | 7.68M | 8.56M | 10.35M | 7.08M | 17.49M | 3.99M | 3.05M | 17.87M | 6.08M |
Total current assets | 133.54M | 353.46M | 249.87M | 393.34M | 338.48M | 532.82M | 378.74M | 528.50M | 237.47M | 326.76M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 45.35M | 52.00M | 53.34M | 59.68M | 59.24M | 13.17M | 10.15M | 8.46M | 9.87M | 9.66M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 836K | 67.53M | 12.75M | 4.98M | 11.86M | 41.58M | 91.56M | 50.86M | 51.39M |
Other non-current assets | 203.10M | 201.09M | 4.06M | 3.28M | 6.10M | 2.36M | 10.90M | 10.72M | 1.91M | -50.06M |
Total non-current assets | 248.45M | 253.93M | 124.94M | 75.71M | 70.33M | 27.41M | 62.65M | 110.75M | 62.64M | 11.00M |
Total assets | 381.99M | 607.4M | 374.81M | 469.05M | 408.82M | 560.23M | 441.4M | 639.25M | 300.11M | 337.77M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 24K | 98K | 11.52M | 31.57M | 43.40M | 125K | 152K | 144K | 89K |
Short term debt | 7.84M | 28.71M | 17.44M | 29.20M | 17.61M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 24.76M | 28.71M | 58.58M | 123.57M | 111.70M | 98.55M | 62.55M | 49.26M | 49.47M | 41.25M |
| Non-current liabilities: | ||||||||||
Long term debt | 45.23M | 45.40M | 652.07M | 647.05M | 492.91M | 454.35M | 223.74M | 222.67M | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 99.00M | 27.09M | 2.73M | 2.18M | 28.04M | 58.91M | 39.92M | 17.07M | 7.58M | 6.72M |
Total non-current liabilities | 144.23M | 136.88M | 654.80M | 649.23M | 520.96M | 513.27M | 263.67M | 239.75M | 7.58M | 6.72M |
Total liabilities | 169.00M | 165.6M | 713.39M | 772.80M | 632.66M | 611.82M | 326.22M | 289.02M | 57.05M | 47.98M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |